NCT04958291View on ClinicalTrials.gov

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CC-99677 in Healthy Adult Japanese Participants.

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

August 3, 2021

Primary Completion Date

December 6, 2021

Study Completion Date

December 7, 2021

Conditions
Healthy Volunteers
Interventions
DRUG

CC-99677

CC-99677

OTHER

Placebo

Placebo

Trial Locations (2)

90806

Collaborative Neuroscience Network, LLC, Long Beach

Local Institution - 001, Long Beach

Sponsors

Lead Sponsor

Celgene
All Listed Sponsors
lead

Celgene

INDUSTRY